BioSamples results for leukemia

Page 123456..57
Page size 2550100250500
Showing 1 - 50 of 2837 SampleGroups
4 Homo sapiens samples from ENA SRA4
GSE48059: Characterization of miRNomes in acute and chronic myeloid leukemia cells3
Genomic targets of the KRAB and scan domain-containing zinc finger protein 263 (ZNF263).2
MHC II peptides, IFNg activated2
COSMIC - PHF6 mutations in adult acute myeloid leukemia.353
COSMIC - Analysis of the p53 gene mutations in acute myelogenous leukemia: the p53 gene mutations associated with a deletion of chromosome 17.18
COSMIC - KIT(D816V+) systemic mastocytosis associated with KIT(D816V+) acute erythroid leukaemia: first case report with molecular evidence for same progenitor cell derivation.3
COSMIC - Response to imatinib in a patient with chronic myeloid leukemia simultaneously expressing p190(BCR-ABL) oncoprotein and JAK2V617F mutation.1
COSMIC - Unexpected phenotype of a typical NPM1 mutant.2
COSMIC - DNMT3A mutations in acute myeloid leukemia.281
COSMIC - Expression of ARC (apoptosis repressor with caspase recruitment domain), an antiapoptotic protein, is strongly prognostic in AML.511
COSMIC - TET2 mutations in childhood leukemia.151
COSMIC - Evaluation of beta-catenin activating mutations in chronic myeloid leukemia.97
COSMIC - A patient with a 20-year lag phase between JAK2-V617F+ myeloproliferation and NPM1-mutated AML arguing against a common origin of disease.3
COSMIC - Prognostic impact of white blood cell count in intermediate risk acute myeloid leukemia: relevance of mutated NPM1 and FLT3-ITD.525
COSMIC - Key pathways are frequently mutated in high-risk childhood acute lymphoblastic leukemia: a report from the Children's Oncology Group.187
COSMIC - Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy.213
COSMIC - Wild-type JAK2 secondary acute erythroleukemia developing after JAK2-V617F-mutated primary myelofibrosis.2
COSMIC - ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.188
COSMIC - NOTCH1 mutations in T-cell acute lymphoblastic leukemia: prognostic significance and implication in multifactorial leukemogenesis.147
COSMIC - Serial determination of FLT3 mutations in myelodysplastic syndrome patients at diagnosis, follow up or acute myeloid leukaemia transformation: incidence and their prognostic significance.194
COSMIC - The angioregulatory phenotype of native human acute myelogenous leukemia cells: influence of karyotype, Flt3 abnormalities and differentiation status.65
COSMIC - Chronic myeloid leukemia patients with F317L BCR-ABL kinase domain mutation are resistant to dasatinib: is that true for all the patients?1
COSMIC - Clinical outcome of chronic myeloid leukemia imatinib-resistant patients: do BCR-ABL kinase domain mutations affect patient survival? First multicenter Argentinean study.136
Expression profiling by array in ATLL2
COSMIC - CKIT mutation in therapy-related acute myeloid leukemia with MLLT3/MLL chimeric transcript from t(9;11)(p22;q23).1
COSMIC - Mutations of the ras protooncogenes in chronic myelogenous leukemia: a high frequency of ras mutations in bcr/abl rearrangement-negative chronic myelogenous leukemia.132
COSMIC - Point mutations of the N-ras gene in the blood plasma DNA of patients with myelodysplastic syndrome or acute myelogenous leukaemia.10
COSMIC - Dynamic change of T315I BCR-ABL kinase domain mutation in Korean chronic myeloid leukaemia patients during treatment with Abl tyrosine kinase inhibitors.110
COSMIC - Importance of c-kit mutation detection method sensitivity in prognostic analyses of t(8;21)(q22;q22) acute myeloid leukemia.40
COSMIC - TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.601
COSMIC - Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.91
COSMIC - Molecular analysis of PDGFRalpha/beta genes in core binding factor leukemia with eosinophilia.21
COSMIC - ETS-related gene ERG expression in AML patients is significantly associated with NPM1 mutation status.96
COSMIC - Application of a BRAF V600E mutation-specific antibody for the diagnosis of hairy cell leukemia.56
COSMIC - Trisomy 13 correlates with RUNX1 mutation and increased FLT3 expression in AML-M0 patients.52
COSMIC - STAT3 mutations are highly specific for large granular lymphocytic leukemia.139
COSMIC - Detection of NOTCH1 mutations in adult T-cell leukemia/lymphoma and peripheral T-cell lymphoma.53
COSMIC - Erlotinib in a patient with acute myelogenous leukemia and concomitant non-small-cell lung cancer.1
COSMIC - Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia.16
COSMIC - Detection of NPM1 exon 12 mutations and FLT3 - internal tandem duplications by high resolution melting analysis in normal karyotype acute myeloid leukemia.44
COSMIC - Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients.1
COSMIC - Capillary gel electrophoresis: a simple method for identification of mutations and polymorphisms in the CEBPA gene in patients with acute myeloid leukaemia.485
COSMIC - Sustained NF-kappaB activity in chronic lymphocytic leukemia is independent of genetic and epigenetic alterations in the TNFAIP3 (A20) locus.55
COSMIC - AML engraftment in the NOD/SCID assay reflects the outcome of AML: implications for our understanding of the heterogeneity of AML.29
COSMIC - Analysis of JAK3, JAK2, and C-MPL mutations in transient myeloproliferative disorder and myeloid leukemia of Down syndrome blasts in children with Down syndrome.22
COSMIC - Molecular and clinicopathologic characterization of AML with isolated trisomy 4.11
COSMIC - JAK2 V617F is a rare finding in de novo acute myeloid leukemia, but STAT3 activation is common and remains unexplained.202
COSMIC - Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns.5
COSMIC - Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.239